HR

Healthcare Realty Trust Announces Key Leadership Changes

Healthcare Realty Trust has announced key leadership changes in a move to increase focus on execution, growth acceleration, and accretive capital allocation. The company's board of directors has appointed Rob Hull as Chief Operating Officer, Ryan Crowley as Executive Vice President and Chief Investment Officer, and Julie Wilson as Chief Administrative Officer. Additionally, Austen Helfrich will take on the role of interim Chief Financial Officer.

Rob Hull, who has served as Executive Vice President of Investments since 2017, will now oversee the company’s portfolio performance. Under his leadership, the leasing team has achieved over 400,000 square feet in new leasing volume for four consecutive quarters and driven more than a 110 basis points improvement in occupancy over the last three quarters.

Ryan Crowley, who has been with the company for over 18 years, will be responsible for acquisitions, dispositions, and re/development. His track record includes leading the company’s acquisition efforts since 2018, completing over $2.3 billion of acquisitions, and being directly involved with investment transactions valued at more than $5 billion.

Julie Wilson, who has overseen the largest portion of the company’s over 550 employees as Executive Vice President of Operations since 2021, will take on the role of Chief Administrative Officer, adding human resources to her current leadership responsibilities.

The company also reaffirmed its guidance for the third quarter and full year 2024, including normalized FFO per share and all other forward-looking guidance provided with the company’s second quarter earnings release.

Austen Helfrich, the interim Chief Financial Officer, has been responsible for the company’s joint venture and dispositions strategy, leading the formation and expansion of the company’s joint venture program, including partnerships with Nuveen, CBRE Investment Management, and KKR.

Healthcare Realty Trust, a real estate investment trust (REIT) that owns and operates medical outpatient buildings, selectively grows its portfolio through property acquisition and development. Its portfolio includes nearly 675 properties totaling approximately 40 million square feet, concentrated in 15 growth markets.

The company plans to provide additional commentary on its expected 2024 earnings and business updates during its third-quarter earnings call. Following these announcements, the company's shares moved -0.7%, and are now trading at a price of $18.64. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS